{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:19:41Z","timestamp":1791231581322,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ecl.2018.04.012","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T18:25:38Z","timestamp":1533752738000},"page":"671-682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Carcinoid Heart Disease"],"prefix":"10.1016","volume":"47","author":[{"given":"Aimee R.","family":"Hayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Davar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn E.","family":"Caplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ecl.2018.04.012_bib1","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka","year":"1993","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ecl.2018.04.012_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.CIR.77.2.264","article-title":"Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities","volume":"77","author":"Lundin","year":"1988","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ecl.2018.04.012_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.amjcard.2007.08.045","article-title":"Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century","volume":"101","author":"Bhattacharyya","year":"2008","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ecl.2018.04.012_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCIMAGING.109.886846","article-title":"Features of carcinoid heart disease identified by two- and three-dimensional echocardiography and cardiac magnetic resonance imaging","volume":"3","author":"Bhattacharyya","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ecl.2018.04.012_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0735-1097(94)00374-Y","article-title":"Outcome of cardiac surgery for carcinoid heart disease","volume":"25","author":"Connolly","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.ecl.2018.04.012_bib6","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1161\/CIRCULATIONAHA.105.553750","article-title":"Prognosis of carcinoid heart disease","volume":"112","author":"M\u00f8ller","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ecl.2018.04.012_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000381930","article-title":"Carcinoid heart disease: from pathophysiology to treatment-\u2018Something in the way it moves'","volume":"101","author":"Grozinsky-Glasberg","year":"2015","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.ecl.2018.04.012_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","article-title":"Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography","volume":"92","author":"Robiolio","year":"1995","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ecl.2018.04.012_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0735-1097(98)00354-4","article-title":"Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease","volume":"32","author":"Denney","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ecl.2018.04.012_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine\u2013phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ecl.2018.04.012_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJM199809103391101","article-title":"The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs","volume":"339","author":"Khan","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.ecl.2018.04.012_bib12","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT 2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ecl.2018.04.012_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine","volume":"57","author":"Fitzgerald","year":"2000","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.ecl.2018.04.012_bib14","first-page":"827","article-title":"Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects","volume":"10","author":"Rajamannan","year":"2001","journal-title":"J\u00a0Heart Valve Dis"},{"issue":"2","key":"10.1016\/j.ecl.2018.04.012_bib15","first-page":"256","article-title":"Expression of 5-hydroxytryptamine receptor subtype messenger RNA in interstitial cells from human heart valves","volume":"9","author":"Roy","year":"2000","journal-title":"J\u00a0Heart Valve Dis"},{"issue":"5","key":"10.1016\/j.ecl.2018.04.012_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1369\/jhc.4A6500.2005","article-title":"5-Hydroxytryptamine (5HT) receptors in the heart valves of cynomolgus monkeys and Sprague-Dawley rats","volume":"53","author":"Elangbam","year":"2005","journal-title":"J\u00a0Histochem Cytochem"},{"issue":"4","key":"10.1016\/j.ecl.2018.04.012_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.etp.2008.03.005","article-title":"5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats","volume":"60","author":"Elangbam","year":"2008","journal-title":"Exp Toxicol Pathol"},{"issue":"12","key":"10.1016\/j.ecl.2018.04.012_bib18","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/01.CIR.0000159356.42064.48","article-title":"Long-term serotonin administration induces heart valve disease in rats","volume":"111","author":"Gustafsson","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ecl.2018.04.012_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.regpep.2007.02.009","article-title":"Long-term serotonin effects in the rat are prevented by terguride","volume":"143","author":"Hauso","year":"2007","journal-title":"Regul Pept"},{"issue":"3","key":"10.1016\/j.ecl.2018.04.012_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/01.RES.0000136520.07995.aa","article-title":"Valvular myofibroblast activation by transforming growth factor-\u03b2","volume":"95","author":"Walker","year":"2004","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.ecl.2018.04.012_bib21","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/j.1572-0241.2004.40507.x","article-title":"Carcinoid tumors and fibrosis: an association with no explanation","volume":"99","author":"Modlin","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ecl.2018.04.012_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000318014","article-title":"Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis","volume":"92","author":"Bergestuen","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.ecl.2018.04.012_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0025-6196(11)62328-8","article-title":"Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years","volume":"77","author":"Simula","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.ecl.2018.04.012_bib24","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0735-1097(02)02109-5","article-title":"Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients","volume":"40","author":"Pandya","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ecl.2018.04.012_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0002-9343(64)90145-7","article-title":"The cardiac disease associated with the carcinoid syndrome (carcinoid heart disease)","volume":"36","author":"Roberts","year":"1964","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ecl.2018.04.012_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0046-8177(76)80054-8","article-title":"The carcinoid endocardial plaque: an ultrastructural study","volume":"7","author":"Ferrans","year":"1976","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.ecl.2018.04.012_bib27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.1983.1.11.727","article-title":"Treatment of the carcinoid tumor and the malignant carcinoid syndrome","volume":"1","author":"Moertel","year":"1983","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ecl.2018.04.012_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(85)90313-4","article-title":"The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease","volume":"79","author":"Ross","year":"1985","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ecl.2018.04.012_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0002-9149(97)00340-8","article-title":"A\u00a0unique heart disease associated with a unique cancer: carcinoid heart disease","volume":"80","author":"Roberts","year":"1997","journal-title":"Am J Cardiol"},{"issue":"suppl 1","key":"10.1016\/j.ecl.2018.04.012_bib30","doi-asserted-by":"crossref","first-page":"I36","DOI":"10.1161\/hc37t1.094898","article-title":"Surgical management of left-sided carcinoid heart disease","volume":"104","author":"Connolly","year":"2001","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ecl.2018.04.012_bib31","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/CIRCULATIONAHA.107.701367","article-title":"Carcinoid heart disease","volume":"116","author":"Bhattacharyya","year":"2007","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ecl.2018.04.012_bib32","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/CIRCULATIONAHA.108.776021","article-title":"Right-sided valve disease deserves a little more respect","volume":"119","author":"Bruce","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ecl.2018.04.012_bib33","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.CIR.11.4.552","article-title":"The diagnosis of tricuspid insufficiency","volume":"11","author":"Sepulveda","year":"1955","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ecl.2018.04.012_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0002-9343(62)90281-4","article-title":"Rheumatic tricuspid regurgitation: the clinical spectrum","volume":"33","author":"Salazar","year":"1962","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ecl.2018.04.012_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/hrt.16.2.195","article-title":"Tricuspid incompetence","volume":"16","author":"M\u00fcller","year":"1954","journal-title":"Br Heart J"},{"issue":"6","key":"10.1016\/j.ecl.2018.04.012_bib36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pcad.2006.12.002","article-title":"Carcinoid heart disease","volume":"49","author":"Bernheim","year":"2007","journal-title":"Prog Cardiovasc Dis"},{"issue":"7","key":"10.1016\/j.ecl.2018.04.012_bib37","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/cncr.11226","article-title":"Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor","volume":"97","author":"Zuetenhorst","year":"2003","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ecl.2018.04.012_bib38","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021451","article-title":"Factors associated with progression of carcinoid heart disease","volume":"348","author":"M\u00f8ller","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ecl.2018.04.012_bib39","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.amjcard.2010.12.025","article-title":"Risk factors for the development and progression of carcinoid heart disease","volume":"107","author":"Bhattacharyya","year":"2011","journal-title":"Am J Cardiol"},{"issue":"26","key":"10.1016\/j.ecl.2018.04.012_bib40","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2008.18.7047","article-title":"Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor","volume":"27","author":"Korse","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ecl.2018.04.012_bib41","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/endo.132.5.8477647","article-title":"Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching","volume":"132","author":"Kinnunen","year":"1993","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.ecl.2018.04.012_bib42","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.amjcard.2008.05.047","article-title":"Usefulness of N-terminal pro\u2013brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease","volume":"102","author":"Bhattacharyya","year":"2008","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ecl.2018.04.012_bib43","first-page":"E4","article-title":"Utility of 3D transoesophageal echocardiography for the assessment of tricuspid and pulmonary valves in carcinoid heart disease","volume":"12","author":"Bhattacharyya","year":"2011","journal-title":"Eur J Echocardiogr"},{"issue":"2","key":"10.1016\/j.ecl.2018.04.012_bib44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000471879","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine and hybrid imaging","volume":"105","author":"Sundin","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.ecl.2018.04.012_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1200\/JCO.2016.69.2780","article-title":"Telotristat ethyl, a tryptophan hydroxylase inhibitor for the treatment of carcinoid syndrome","volume":"35","author":"Kulke","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"20","key":"10.1016\/j.ecl.2018.04.012_bib46","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.jacc.2015.09.014","article-title":"Early and late outcomes of surgical treatment in carcinoid heart disease","volume":"66","author":"Connolly","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12 suppl 1","key":"10.1016\/j.ecl.2018.04.012_bib47","first-page":"I51","article-title":"Carcinoid heart disease: impact of pulmonary valve replacement in right ventricular function and remodeling","volume":"106","author":"Connolly","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ecl.2018.04.012_bib48","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2016.12.030","article-title":"Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumours","volume":"69","author":"Davar","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2018.04.012_bib49","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ecl.2018.04.012_bib50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.athoracsur.2010.11.009","article-title":"Society of Thoracic Surgeons adult cardiac surgical database. Fifteen-year outcome trends for valve surgery in North America","volume":"91","author":"Lee","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.ecl.2018.04.012_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5223(19)37666-4","article-title":"Porcine heterograft valve replacement in carcinoid heart disease","volume":"81","author":"Schoen","year":"1981","journal-title":"J\u00a0Thorac Cardiovasc Surg"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852918305243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852918305243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:44:07Z","timestamp":1760175847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852918305243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0889852918305243"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2018.04.012","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carcinoid Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2018.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}